WBRT
Showing 51 - 75 of 271
Brain Metastases, Adult, CNS Metastases Trial in São Paulo (Intraoperative Radiotherapy)
Active, not recruiting
- Brain Metastases, Adult
- Central Nervous System Metastases
- Intraoperative Radiotherapy
-
São Paulo, SP, BrazilAC Camargo Cancer Center
Aug 11, 2021
Brain Metastases, Nsclc Trial in Heidelberg (SRS, Whole Brain Radiotherapy)
Recruiting
- Brain Metastases
- Nsclc
- SRS
- Whole Brain Radiotherapy
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Radiation Oncology
May 13, 2022
Breast Cancer, Brain Metastases, Adult, Stereotactic Radiosurgery Trial in Chandigarh (Stereotactic Radiosurgery)
Recruiting
- Breast Cancer
- +3 more
- Stereotactic Radiosurgery
-
Chandigarh, IndiaBudhi Singh Yadav
Dec 1, 2021
Local Tumor Recurrence, Toxicity Trial in Salzburg (HIOB)
Recruiting
- Local Neoplasm Recurrence
- Toxicity
- HIOB
-
Salzburg, AustriaParacelsus private university; University Clinic of Radio-Oncolo
Dec 4, 2021
Brain Metastases Trial in Toronto (Sunitinib)
Completed
- Brain Metastases
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Oct 6, 2022
Cognitive Impairment, Metastatic Malignant Tumor in the Brain, Solid Tumor Trial in Canada, United States (Whole brain radiation
Completed
- Cognitive Impairment
- +2 more
- Whole brain radiation therapy with hippocampal avoidance
- +2 more
-
Tuscaloosa, Alabama
- +219 more
May 12, 2021
Radiation OmisSion in PAtients With CLinically Node Negative
Not yet recruiting
- Breast Cancer
- (no location specified)
May 10, 2023
HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Canada, Korea,
Completed
- HER2-Positive Breast Carcinoma
- +4 more
- Laboratory Biomarker Analysis
- +3 more
-
Birmingham, Alabama
- +301 more
Jun 28, 2022
Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Shanghai (Pyrotinib Plus Capecitabine combined with brain
Active, not recruiting
- Breast Cancer
- +2 more
- Pyrotinib Plus Capecitabine combined with brain radiotherapy
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 14, 2023
Tumors Metastatic to Brain, Solid Tumor Trial in Bronx (diffusion tensor imaging, whole-brain radiation therapy, stereotactic
Withdrawn
- Tumors Metastatic to Brain
- Unspecified Adult Solid Tumor, Protocol Specific
- diffusion tensor imaging
- +4 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Mar 2, 2020
Brain Metastases, Adult Trial (Hypofractionated Radiosurgery (HSRS), Brain metastases surgical resection)
Not yet recruiting
- Brain Metastases, Adult
- Hypofractionated Radiosurgery (HSRS)
- Brain metastases surgical resection
- (no location specified)
Oct 4, 2022
Prospective Neurobehavioral Functions in Newly-diagnosed Primary
Recruiting
- Primary CNS Lymphoma
- Brain Lymphoma
- A treatment protocol of combined chemoradiation delivered in the manner of hyperfractionated conformal whole-brain radiation therapy
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Mar 9, 2021
Cerebral Metastases, Surgery Trial in Düsseldorf (Cavity boost radiation)
Recruiting
- Cerebral Metastases
- Surgery
- Cavity boost radiation
-
Düsseldorf, NRW, GermanyHeinrich-Heine-University
Mar 21, 2022
Non Small Cell Lung Cancer, Brain Metastases Trial in Hangzhou (Icotinib, SRS/WBRT/HA-WBRT/SMART)
Unknown status
- Non Small Cell Lung Cancer
- Brain Metastases
- Icotinib
- SRS/WBRT/HA-WBRT/SMART
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Aug 13, 2019
HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,
Recruiting
- HER2-positive Breast Cancer
- +2 more
- Radiation Therapy
- +2 more
-
Tampa, Florida
- +1 more
Dec 30, 2022
Metastatic Non Small Cell Lung Cancer Trial in Australia, Singapore (Osimertinib, Stereotactic Radiosurgery (SRS))
Recruiting
- Metastatic Non Small Cell Lung Cancer
- Osimertinib
- Stereotactic Radiosurgery (SRS)
-
Newcastle, New South Wales, Australia
- +12 more
Nov 16, 2022
NSCLC Stage IV Trial in Spain (Atezolizumab)
Completed
- Non-small Cell Lung Cancer Stage IV
-
Elche, Alicante, Spain
- +14 more
Jan 26, 2023
Primary CNS Lymphoma Trial in Zhengzhou (the dose-escalation phase)
Recruiting
- Primary Central Nervous System Lymphoma
- the dose-escalation phase
-
Zhengzhou, Henan, ChinaOncology Department of The First Affiliated Hospital of Zhengzho
May 30, 2022
Patients Receiving Radiation Therapy for Brain Metastases
Recruiting
- Brain Metastasis
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 27, 2023
Breast Cancer Trial in Marseille (Whole breast radiotherapy, Intra Operative Radiotherapy)
Recruiting
- Breast Cancer
- Whole breast radiotherapy
- Intra Operative Radiotherapy
-
Marseille, FranceInstitut Paoli-Calmettes
Feb 28, 2022
Brain Metastases, Adult Solid Tumor Trial in Heidelberg (stereotactic radiosurgery (SRS))
Active, not recruiting
- Brain Metastases
- Adult Solid Tumor
- stereotactic radiosurgery (SRS)
-
Heidelberg, GermanyUniversity Hospital of Heidelberg, Department of Radiation Oncol
Sep 28, 2021
Non Small Cell Lung Cancer Trial in Changsha (radiotherapy, Chemotherapy + immunotherapy)
Not yet recruiting
- Non Small Cell Lung Cancer
- radiotherapy
- Chemotherapy + immunotherapy
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Oct 17, 2022
Recurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain Trial in Columbus, Philadelphia (Ipilimumab, Whole-Brain
Brain Metastases, Small Cell Lung Cancer Trial in Birmingham (NovoTTF-200A, Stereotactic Radiosurgery (SRS))
Terminated
- Brain Metastases
- Small Cell Lung Cancer
- NovoTTF-200A
- Stereotactic Radiosurgery (SRS)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham (UAB), Hazelrig-Salter Radia
Feb 17, 2022